Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Turnstone Biologics Corp. - Common Stock (NQ: TSBX ) 2.176 +0.016 (+0.75%) Streaming Delayed Price Updated: 10:21 AM EDT, Aug 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,942 Open 2.220 Bid (Size) 2.120 (1) Ask (Size) 2.190 (2) Prev. Close 2.160 Today's Range 2.176 - 2.220 52wk Range 1.625 - 12.80 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Monday's After-Market Session May 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 16, 2024 Via Benzinga Performance YTD -15.98% -15.98% 1 Month -3.71% -3.71% 3 Month -33.04% -33.04% 6 Month -3.71% -3.71% 1 Year -80.69% -80.69% More News Read More TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024 May 13, 2024 Via InvestorPlace Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights May 13, 2024 From Turnstone Biologics Corp. Via GlobeNewswire Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference May 08, 2024 From Turnstone Biologics Corp. Via GlobeNewswire Turnstone Biologics Appoints William Waddill to its Board of Directors April 16, 2024 From Turnstone Biologics Corp. Via GlobeNewswire TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023 March 22, 2024 Via InvestorPlace Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights March 21, 2024 From Turnstone Biologics Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session March 19, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session March 08, 2024 Via Benzinga Turnstone Biologics to Participate in Upcoming Investor Conferences February 21, 2024 From Turnstone Biologics Corp. Via GlobeNewswire Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq. February 20, 2024 From Turnstone Biologics Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session February 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 23, 2024 Via Benzinga Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference November 27, 2023 From Turnstone Biologics Corp. Via GlobeNewswire Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights November 09, 2023 From Turnstone Biologics Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session November 03, 2023 Via Benzinga Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting November 03, 2023 From Turnstone Biologics Corp. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 01, 2023 Via Benzinga Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber October 30, 2023 From Turnstone Biologics Corp. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday October 10, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Monday's Intraday Session October 09, 2023 Via Benzinga Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session October 03, 2023 Via Benzinga Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting September 28, 2023 From Turnstone Biologics Corp. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
